A study to assess the drug absorption into the blood after administration of 3 doses of AZD5718

Trial Identifier: D7550C00009
Sponsor:AstraZeneca
Collaborator:
Parexel
NCTID:NCT04087187
Start Date:September 2019
Primary Completion Date: October 2019
Study Completion Date: October 2019
Condition: Coronary Artery Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

LanguageDescription
English version

Trial Locations

CountryLocation
United Kingdom London, United Kingdom, HA1 3UJ